KROS filings
Corporate insider profile
Julius Knowles Filing Activity
Latest reported as Director of Keros Therapeutics, Inc. (KROS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$28,166.25
- Latest transaction
- Jun 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
